Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/13/20
Alpine Immune Sciences Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateBusiness Wire • 11/12/20
Alpine Immune Sciences to Report Third Quarter 2020 Financial Results and Provide Corporate UpdateBusiness Wire • 11/05/20
Alpine Immune Sciences to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech SummitBusiness Wire • 09/15/20
Alpine Immune Sciences to Present at H.C. Wainwright 22nd Annual Global Investment ConferenceBusiness Wire • 09/08/20
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/12/20
Alpine Immune Sciences Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateBusiness Wire • 08/11/20
Alpine Immune Sciences to Present at 2020 Wedbush PacGrow Healthcare Virtual ConferenceBusiness Wire • 08/05/20
Alpine Immune Sciences to Report Second Quarter 2020 Financial Results and Provide Corporate UpdateBusiness Wire • 08/04/20
Alpine Immune Sciences, Inc. (ALPN) Shares March Higher, Can It Continue?Zacks Investment Research • 07/08/20
Shares of Alpine Immune Sciences rise after biotech lands $60M from AbbVie for lupus drugGeekWire • 06/19/20
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/31/20
Analysts Estimate Alpine Immune Sciences (ALPN) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 08/01/19
Earnings Preview: Alpine Immune Sciences (ALPN) Q1 Earnings Expected to DeclineZacks Investment Research • 05/06/19